Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

Todd Neale

March 22, 2022

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Todd Neale

December 14, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Todd Neale

June 22, 2015

News Daily News

实际病例研究认为磺达肝素治疗 NSTEMI 的效果优于肝素

Todd Neale

February 22, 2015

News Daily News

Un Estudio del Mundo Real Avala el Uso de Fondaparinux sobre Heparina en el Manejo de los cuadros de NSTEMI

Todd Neale

February 22, 2015

News Daily News

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

Todd Neale

February 22, 2015

News Daily News

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

L.A. McKeown

November 17, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Advertisement

October 2023 News Roundup

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Study Affirms Thrombotic Risk in COVID-19

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Elderly Women Worse Off Than Men Before and After Acute MI

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

实际病例研究认为磺达肝素治疗 NSTEMI 的效果优于肝素

Un Estudio del Mundo Real Avala el Uso de Fondaparinux sobre Heparina en el Manejo de los cuadros de NSTEMI

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content